发疱性抗肿瘤药物注射外漏可能引起皮肤和结构的局部坏死、功能损害等严重不良反应。据报道其发生率在0.5％～6％。通常对渗漏的处理主要是凭经验、临床病例报道或生产厂商说明以及动物模型研究进行处理。因而缺乏正确资料。作者根据在约600床位的教学医院的临床药师、医师、护士多 The leakage of the blistering anticancer drug injection may cause serious necrosis of the skin and structure, necrosis and other serious adverse effects. It is reported that the incidence of 0.5% to 6%. The usual treatment of leaks is based on experience, clinical case reports or manufacturer’s instructions and animal model studies. Therefore, the lack of correct information. The author is based on more than 600 clinical pediatric physicians, physicians, and nurses in teaching hospitals